N-caffeoyltryptamine
structure in first source
Also Known As:
safflomide
Networked: 2
relevant articles (1 outcomes,
0 trials/studies)
Relationship Network
Bio-Agent Context: Research Results
Experts
Related Diseases
1. | Body Weight (Weight, Body)
06/01/2007
- " Using this HPLC method, the plasma concentrations of safflomide were determined in mouse blood, collected at 5, 10, 15, 20, 25, 30, and 35 min following its oral administrations (1 and 3 mg/30 g body weight). " 04/25/2012
- " Rats supplemented with safflomide (3 mg/day) in a high-fat diet showed a significant plasma adiponectin increase (more than 30%) with a significant reduction in body weight, visceral fat, and improved insulin resistance compared to non-supplemented rats, demonstrating the in vivo activity of safflomide. "
|
2. | Insulin Resistance
|
3. | Abdominal Obesity
|
4. | Obesity
|
|
Related Drugs and Biologics
Related Therapies and Procedures